<DOC>
	<DOCNO>NCT01033305</DOCNO>
	<brief_summary>This multi-center study Ireland United Kingdom determine effect , safety tolerability drug call CyCol™ improve mild moderate ulcerative colitis ( UC ) . Informed consent obtain follow confirmation eligibility disease assessment , study participant randomise ( allocated chance ) take either CyCol™ , placebo , orally every day four week . Study visit assessment include blood stool test , physical examination flexible sigmoidoscopy ( inspection bowel wall use flexible camera ) . Half participant receive CyCol™ half receive placebo . At end treatment ( 4 week ) study participant reassess finding receive CyCol™ compare receive placebo . Any side effect experience study safety treatment CyCol™ also evaluate .</brief_summary>
	<brief_title>Oral Ciclosporin Colonic Release Ulcerative Colitis ( CyCol™ )</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>Male female age &gt; 18 year Diagnosis mild moderate diagnosis UC involve least rectum sigmoid colon Clinical severity assess screen use Disease Activity Index ( DAI ) Clinical severity document confirm flexible sigmoidoscopy , within 7 day start study treatment Signed date write informed consent . Willing maintain current UC medication dose regimen screen end 4week treatment period . Able willing refrain intake St. Johns Wort prescription , overthecounter , herbal preparation know affect cytochrome P450 metabolism throughout 4week treatment period . Able willing refrain intake grapefruit grapefruit juice food drink know affect cytochrome P450 metabolism throughout 4 week treatment period study . Severe fulminant UC . UC limit rectum . Any previous colonic surgery . Any histological evidence dysplasia colonoscopic biopsy . Women childbearing potential unable unwilling use adequate contraceptive method avoid pregnancy . Previous unsuccessful ciclosporin therapy . Biologic therapy within past 2 month prior study treatment . Methotrexate therapy within 4 week study treatment . A steroid treatment dose great 10 mg/day prednisolone ( equivalent ) within 4 week study treatment . Use topical treatment ( e.g . enema ) within 4 week study treatment unwilling refrain use topical treatment screen visit end 4week treatment period . Significant renal impairment , hepatic impairment , uncontrolled hypertension , premalignant skin lesion current malignancy , severe comorbid condition . Known hypersensitivity ciclosporin excipients . Positive screen stool assay Clostridium difficile , hemorrhagic E.coli 0157 : H7 , Salmonella Shigella Diagnosis Crohn 's colitis , ischemic colitis , NSAIDinduced colitis , radiation colitis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>UC</keyword>
</DOC>